Links
Tools
Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial
Journal article published in 2016 by
Ayman Elbadawi,
Gerald Gasioch,
Islam Y. Elgendy 
,
Ahmed N. Mahmoud,
Le Dung Ha,
Haitham Al Ashry,
Hend Shahin,
Mohamed A. Hamza,
Ahmed S. Abuzaid,
Marwan Saad
,
Ahmed N. Mahmoud,
Le Dung Ha,
Haitham Al Ashry,
Hend Shahin,
Mohamed A. Hamza,
Ahmed S. Abuzaid,
Marwan Saad
Abstract
Introduction : The role of intracoronary (IC) eptifibatide in primary percutaneous coronary intervention (PPCI) for ST segment elevation myocardial infarction (STEMI) and whether time of patient presentation affects this role are unclear. We sought to evaluate the benefit of IC eptifibatide use during primary PCI in early STEMI presenters compared to late STEMI presenters. ; Methods : We included 70 patients who presented with STEMI and were eligible for PPCI. On the basis of symptom-to-door time, patients were classified into two arms: early (